Metabolic syndrome, C-reactive protein and microalbuminuria in a rural Chinese population: a cross-sectional study

[1]  J. Lopes,et al.  Metabolic Syndrome, Chronic Kidney Disease, and Cardiovascular Disease: A Dynamic and Life-Threatening Triad , 2011, Cardiology research and practice.

[2]  Yu Chen,et al.  The prevalence of microalbuminuria and its relationships with the components of metabolic syndrome in the general population of China. , 2010, Clinica chimica acta; international journal of clinical chemistry.

[3]  T. Wong,et al.  C-reactive protein and microalbuminuria in a multi-ethnic Asian population. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[4]  Ningli Wang,et al.  Prevalence of Chronic Kidney Disease in a Rural Chinese Adult Population: The Handan Eye Study , 2010, Nephron Clinical Practice.

[5]  E. Benjamin,et al.  The relation of C - reactive protein to chronic kidney disease in African Americans: the Jackson Heart Study , 2010 .

[6]  M. Mirarefin,et al.  Increased Risk of Chronic Kidney Disease in Elderly with Metabolic Syndrome and High Levels of C-Reactive Protein: Kahrizak Elderly Study , 2010, Kidney and Blood Pressure Research.

[7]  T. Wong,et al.  Association of C-reactive protein and metabolic syndrome in a rural Chinese population. , 2009, Clinical biochemistry.

[8]  E. Mathiesen,et al.  Albuminuria, metabolic syndrome and the risk of mortality and cardiovascular events. , 2009, Atherosclerosis.

[9]  Shufeng Zhou,et al.  Prevalence and risk factors associated with chronic kidney disease in an adult population from southern China. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[10]  D. Friedman,et al.  Prevalence and causes of low vision and blindness in a rural chinese adult population: the Handan Eye Study. , 2008, Ophthalmology.

[11]  H. Bang,et al.  Association of C-reactive protein and microalbuminuria (from the National Health and Nutrition Examination Surveys, 1999 to 2004). , 2008, The American journal of cardiology.

[12]  Jung Eun Lee,et al.  Metabolic syndrome, C-reactive protein, and chronic kidney disease in nondiabetic, nonhypertensive adults. , 2007, American journal of hypertension.

[13]  C-C Lin,et al.  Microalbuminuria and the metabolic syndrome and its components in the Chinese population , 2007, European journal of clinical investigation.

[14]  Li-sheng Liu,et al.  Metabolic syndrome and chronic kidney disease in a Chinese population aged 40 years and older. , 2007, Mayo Clinic proceedings.

[15]  O. Franco,et al.  Distributions of C-reactive protein and its association with metabolic syndrome in middle-aged and older Chinese people. , 2007, Journal of the American College of Cardiology.

[16]  Takeo Kato,et al.  The association between microalbuminuria and metabolic syndrome in the general population in Japan: the Takahata study. , 2007, Internal medicine.

[17]  R. Rodby,et al.  [Clinical and health economic implications of early treatment with irbesartan of patients with type 2 diabetes mellitus, hypertension and nephropathy]. , 2006, Deutsche medizinische Wochenschrift.

[18]  R. Krauss,et al.  Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement , 2005, Current opinion in cardiology.

[19]  P. Kimmel,et al.  Associations of metabolic syndrome with inflammation in CKD: results From the Third National Health and Nutrition Examination Survey (NHANES III). , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[20]  Jing Chen,et al.  Prevalence of the metabolic syndrome and overweight among adults in China , 2005, The Lancet.

[21]  Paul Schoenhagen,et al.  Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease. , 2005, The New England journal of medicine.

[22]  A. Okayama,et al.  Association between serum C-reactive protein levels and microalbuminuria: a population-based cross-sectional study in northern Iwate, Japan. , 2004, Internal medicine.

[23]  W. Jia,et al.  [Relationship between the prevalence of microalbuminuria and components of metabolic syndrome in Shanghai]. , 2004, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.

[24]  M. Carnethon,et al.  Association between microalbuminuria and the metabolic syndrome: NHANES III. , 2003, American journal of hypertension.

[25]  G. Eknoyan,et al.  National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification , 2003, Annals of Internal Medicine.

[26]  Sidney C. Smith,et al.  MARKERS OF INFLAMMATION AND CARDIOVASCULAR DISEASE: APPLICATION TO CLINICAL AND PUBLIC HEALTH PRACTICE: A STATEMENT FOR HEALTHCARE PROFESSIONALS FROM THE CENTERS FOR DISEASE CONTROL AND PREVENTION AND THE AMERICAN HEART ASSOCIATION , 2003 .

[27]  Gary L Myers,et al.  Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. , 2003, Circulation.

[28]  Hans L Hillege,et al.  Urinary Albumin Excretion Predicts Cardiovascular and Noncardiovascular Mortality in General Population , 2002, Circulation.

[29]  Ethan M Balk,et al.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[30]  M. Mariani,et al.  Microalbuminuria, an integrated marker of cardiovascular risk in essential hypertension , 2002, Journal of Human Hypertension.

[31]  S. Yusuf,et al.  Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. , 2001, JAMA.

[32]  N Rifai,et al.  Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study. , 2001, JAMA.

[33]  H. Brenner,et al.  Association between C-reactive protein and features of the metabolic syndrome: a population-based study. , 2000, Diabetes care.

[34]  S. Haffner,et al.  Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis Study. , 2000, Kidney international.

[35]  D. Zeeuw,et al.  Urinary albumin excretion is associated with renal functional abnormalities in a nondiabetic population. , 2000, Journal of the American Society of Nephrology : JASN.